Roger E. Susi
President, CEO and Chairman at iRadimed Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: iRadimed Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
iRadimed Corporation June 24, 202681.4%
-
iRadimed Corporation June 23, 202579.9%
-
iRadimed Corporation June 20, 202483.6%
-
iRadimed Corporation June 15, 202382.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | iRadimed Corporation | Open-market sale | −400 | $88.68 | $35,472 |
| Jun 1, 2026 | iRadimed Corporation | Open-market sale | −775 | $89.79 | $69,587 |
| Jun 1, 2026 | iRadimed Corporation | Open-market sale | −401 | $91.08 | $36,523 |
| Jun 1, 2026 | iRadimed Corporation | Open-market sale | −924 | $91.91 | $84,925 |
| May 27, 2026 | iRadimed Corporation | Open-market sale | −2,167 | $91.85 | $199,039 |
| May 27, 2026 | iRadimed Corporation | Open-market sale | −333 | $92.61 | $30,839 |
| May 26, 2026 | iRadimed Corporation | Open-market sale | −3,111 | $91.81 | $285,621 |
| May 26, 2026 | iRadimed Corporation | Open-market sale | −1,889 | $92.93 | $175,545 |
| May 19, 2026 | iRadimed Corporation | Open-market sale | −653 | $87.13 | $56,896 |
| May 19, 2026 | iRadimed Corporation | Open-market sale | −1,841 | $88.14 | $162,266 |
| May 19, 2026 | iRadimed Corporation | Open-market sale | −6 | $88.65 | $532 |
| May 18, 2026 | iRadimed Corporation | Open-market sale | −298 | $85.95 | $25,613 |
| May 18, 2026 | iRadimed Corporation | Open-market sale | −3,451 | $87.35 | $301,445 |
| May 18, 2026 | iRadimed Corporation | Open-market sale | −1,251 | $88.34 | $110,513 |
| May 12, 2026 | iRadimed Corporation | Open-market sale | −3,307 | $83.70 | $276,796 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.